We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 892 results
  1. Expression of Dystrophin Dp71 Splice Variants Is Temporally Regulated During Rodent Brain Development

    Dystrophin Dp71 is the major product of the Duchenne muscular dystrophy ( DMD ) gene in the brain, and its loss in DMD patients and mouse models leads...

    Mayram González-Reyes, Jorge Aragón, ... Cecilia Montanez in Molecular Neurobiology
    Article Open access 28 May 2024
  2. Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review

    Duchenne muscular dystrophy is a devastating disease that leads to progressive muscle loss and premature death. While medical management focuses...

    Sylwia Szwec, Zuzanna Kapłucha, ... Patryk Konieczny in BioDrugs
    Article Open access 02 November 2023
  3. Trichinella spiralis (Owen, 1835) Induces Increased Dystrophin Expression in Invaded Cross-striated Muscle

    Purpose

    Dystrophin and the dystrophin glycoprotein complex serve as a cytoskeletal integrator, critical for muscle membrane stability. The aim of the...

    Rositsa Milcheva, Iveta Mečiarová, ... Pavel Babál in Acta Parasitologica
    Article 29 March 2023
  4. Dystrophin Short Product, Dp71, Interacts with AQP4 and Kir4.1 Channels in the Mouse Cerebellar Glial Cells in Contrast to Dp427 at Inhibitory Postsynapses in the Purkinje Neurons

    Dystrophin is the causative gene for Duchenne and Becker muscular dystrophy (DMD/BMD), and it produces full-length and short dystrophin, Dp427 and...

    Takahiro Fujimoto, Kirsten Stam, ... Kyoko Itoh in Molecular Neurobiology
    Article 15 March 2023
  5. Evaluation of the dystrophin carboxy-terminal domain for micro-dystrophin gene therapy in cardiac and skeletal muscles in the DMDmdx rat model

    Duchenne muscular dystrophy (DMD) is a muscle wasting disorder caused by mutations in the gene encoding dystrophin. Gene therapy using...

    Audrey Bourdon, Virginie François, ... Caroline Le Guiner in Gene Therapy
    Article 01 February 2022
  6. Brain magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy reveals regional reductions in cerebral gray matter

    Background

    Duchenne muscular dystrophy is a X-linked disease characterized by severe and progressive muscle weakness, alongside cognitive impairment...

    Abbe H. Crawford, Natasha L. Hornby, ... Richard J. Piercy in BMC Neuroscience
    Article Open access 17 March 2023
  7. Identification of Dp140 and α1-syntrophin as novel molecular interactors of the neuronal CaV2.1 channel

    The primary function of dystrophin is to form a link between the cytoskeleton and the extracellular matrix. In addition to this crucial structural...

    Margarita Leyva-Leyva, Alejandro Sandoval, ... Ricardo González-Ramírez in Pflügers Archiv - European Journal of Physiology
    Article 25 March 2023
  8. Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy

    Duchenne muscular dystrophy is a highly progressive muscle wasting disorder due to primary abnormalities in one of the largest genes in the human...

    Kay Ohlendieck, Dieter Swandulla in Pflügers Archiv - European Journal of Physiology
    Article Open access 22 September 2021
  9. Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy

    Duchenne muscular dystrophy (DMD) is caused by frameshift mutations in the DMD gene that prevent the body-wide translation of its protein product,...

    Michael Naidoo, Karen Anthony in Molecular Neurobiology
    Article Open access 13 December 2019
  10. Specific Dystrophins Selectively Associate with Inhibitory and Excitatory Synapses of the Mouse Cerebellum and their Loss Alters Expression of P2X7 Purinoceptors and Pro-Inflammatory Mediators

    Duchenne muscular dystrophy (DMD) patients, having mutations of the DMD gene, present with a range of neuropsychiatric disorders, in addition to the...

    Torquil Jackson, Mohsen Seifi, ... Jerome D. Swinny in Cellular and Molecular Neurobiology
    Article Open access 08 June 2021
  11. Therapeutic approaches for Duchenne muscular dystrophy

    Duchenne muscular dystrophy (DMD) is a monogenic muscle-wasting disorder and a priority candidate for molecular and cellular therapeutics. Although...

    Thomas C. Roberts, Matthew J. A. Wood, Kay E. Davies in Nature Reviews Drug Discovery
    Article 31 August 2023
  12. Severe cardiac involvement with preserved truncated dystrophin expression in Becker muscular dystrophy by +1G>A DMD splice-site mutation: a case report

    Becker muscular dystrophy (BMD) is caused by specific mutations in the DMD gene that causes progressive muscle weakness and primarily affects...

    Ryouhei Komaki, Yasumasa Hashimoto, ... Yuji Takahashi in Journal of Human Genetics
    Article Open access 05 June 2020
  13. Plectin plays a role in the migration and volume regulation of astrocytes: a potential biomarker of glioblastoma

    Background

    The expression of aquaporin 4 (AQP4) and intermediate filament (IF) proteins is altered in malignant glioblastoma (GBM), yet the expression...

    Maja Žugec, Borut Furlani, ... Maja Potokar in Journal of Biomedical Science
    Article Open access 23 January 2024
  14. Regenerative Rehabilitation for Duchenne Muscular Dystrophy

    Duchenne muscular dystrophy (DMD) is a severe, progressive, genetic muscle wasting disorder arising from the absence of the membrane stabilizing...
    Kristy Swiderski, Justin P. Hardee, Gordon S. Lynch in Regenerative Rehabilitation
    Chapter 2022
  15. Truncated SCRIB isoform promotes breast cancer metastasis through HNRNP A1 mediated exon 16 skip**

    Breast cancer is one of the most common malignant tumors with high mortality due to metastases. SCRIB, a scaffold protein mainly distributed in the...

    Bin Zhang, Shao-han **e, ... Feng Wang in Acta Pharmacologica Sinica
    Article 04 July 2023
  16. The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

    During the last decade, multiple clinical trials for Duchenne muscular dystrophy (DMD) have focused on the induction of dystrophin expression using...

    Dominic Scaglioni, Francesco Catapano, ... Francesco Muntoni in Acta Neuropathologica Communications
    Article Open access 06 January 2021
  17. Roles and mechanisms of ankyrin-G in neuropsychiatric disorders

    Ankyrin proteins act as molecular scaffolds and play an essential role in regulating cellular functions. Recent evidence has implicated the ANK3 ...

    Sehyoun Yoon, Nicolas H. Piguel, Peter Penzes in Experimental & Molecular Medicine
    Article Open access 06 July 2022
  18. Cellular pathology of the human heart in Duchenne muscular dystrophy (DMD): lessons learned from in vitro modeling

    Duchenne muscular dystrophy is a genetic disorder where an X-linked mutation in the DMD gene initiates pathogenic development caused by the absence...

    Barbora Svobodova, Sarka Jelinkova, ... Vladimir Rotrekl in Pflügers Archiv - European Journal of Physiology
    Article 24 June 2021
  19. Design and Application of a Short (16-mer) Locked Nucleic Acid Splice-Switching Oligonucleotide for Dystrophin Production in Duchenne Muscular Dystrophy Myotubes

    Splice-switching oligonucleotides (SSOs) have been used to modulate gene expression by interfering with pre-mRNA splicing with the intent to treat...
    Célia Carvalho, Maria Carmo-Fonseca in RNA-Chromatin Interactions
    Protocol 2020
  20. CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy

    Discovery of the CRISPR-Cas (clustered regularly interspaced short palindromic repeat, CRISPR-associated) system a decade ago has opened new...

    Cedric Happi Mbakam, Gabriel Lamothe, ... Jacques P. Tremblay in Neurotherapeutics
    Article 14 February 2022
Did you find what you were looking for? Share feedback.